ELI LILLY & CO (LLY)
Clinical trial NCT03675893 updates: 1. enrollment: 180 → 110 participants 2. collaborators removed: Effector Therapeutics
Clinical trial NCT03675893 updates: 1. enrollment: 180 → 110 participants 2. collaborators removed: Effector Therapeutics
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical